(HealthDay)—Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.
Oct 9, 2013
0
0
(HealthDay)—For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. ...
Aug 29, 2013
0
0
Transplant teams have long tried to match the size of donor lungs to the size of the recipient as closely as possible, concerned that lungs of the wrong size could lead to poor lung function and poor outcomes. But new Johns ...
Aug 1, 2013
0
0
Part of a Japanese woman's lung was transplanted to her three-year-old son Monday in what was described as the world's first successful graft of a middle lobe from a living donor, a hospital said.
Jul 1, 2013
0
0
(Medical Xpress)—Better management of diabetes could dramatically improve outcomes for lung transplant patients, with new research showing that those without diabetes lived twice as long as transplant recipients with the ...
Jun 19, 2013
0
0
Blood diseases such as leukemia, multiple myeloma, and myelodysplasia can develop from abnormal bone marrow cells and a dysfunctional bone marrow microenvironment that surrounds these cells. Until now, researchers have been ...
May 28, 2013
0
0
(HealthDay)—An acute increase in lung allocation score (LAS) before transplantation is associated with worse post-transplant survival, according to a study published in the May 7 issue of the Annals of Internal Medicine.
May 8, 2013
0
0
A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease.
Apr 15, 2013
0
0
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...
Mar 26, 2013
0
0
Research paves the way for new approaches in the treatment of pulmonary arterial hypertension, a progressive lung disease that can lead to heart failure within three years.
Mar 11, 2013
0
0
